Jinwoo Cheon

Title: Jinwoo Cheon: Innovator in Controlled Delivery Systems and MRI Contrast Agents

Introduction

Jinwoo Cheon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of controlled delivery systems and magnetic resonance imaging (MRI) contrast agents. With a total of 2 patents, his work showcases innovative approaches to medical technology.

Latest Patents

One of Jinwoo Cheon's latest patents is a method of controlled delivery using sub-micron-scale machines. This method involves administering a plurality of containment vessels into the body, each containing a substance that is released when exposed to a time-varying magnetic field. The vessels have an average outer diameter of less than about 1 µm, allowing for precise delivery of therapeutic agents.

Another notable patent is related to MRI contrast agents comprising zinc-containing magnetic metal oxide nanoparticles. This invention improves the contrast effect of MRI by utilizing water-soluble metal oxide nanoparticles that incorporate zinc. The nanoparticles can be conjugated with bioactive materials, enhancing their effectiveness in medical imaging.

Career Highlights

Jinwoo Cheon has worked at prestigious institutions, including the University of California and Yonsei University. His research has focused on advancing medical technologies that improve patient outcomes and diagnostic capabilities.

Collaborations

Throughout his career, Jinwoo has collaborated with notable colleagues such as Jeffrey I. Zink and Courtney R. Thomas. These partnerships have contributed to the development of innovative solutions in his field.

Conclusion

Jinwoo Cheon's work exemplifies the intersection of innovation and medical technology. His patents in controlled delivery systems and MRI contrast agents highlight his commitment to advancing healthcare solutions. His contributions continue to impact the medical field positively.